Skip to content

Clinical trials

Phase 2/3 Musculoskeletal Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Musculoskeletal Diseases Phase: Phase 2/3 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20121
20132
20161
20191
20211
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting2
Terminated2
Unknown status1
Not yet recruiting1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ashibio Inc1
BioMarin Pharmaceutical1
Bone Therapeutics S.A1
Corewell Health East1
Nationwide Children's Hospital1
Ochsner Health System1
QED Therapeutics, a BridgeBio company1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1
Universitaire Ziekenhuizen KU Leuven1
University of Melbourne1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Musculoskeletal Diseases13
Bone Diseases4
Arthritis2
Genetic Diseases, Inborn2
Joint Diseases2
Osteoarthritis, Knee2
Osteochondrodysplasias2
Achondroplasia1
Ankylosis1
Blood Loss, Surgical1

Trials

Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.